Moreover, engineered OMV-PD1 can bind to PD-L1 on tumor cell surfaces, promoting internalization and degradation, thereby protecting T cells from the PD1/PD-L1 immune suppression axis23. This evidence concerns the gene CD274 and neoplasm.